Investments
26Portfolio Exits
12Paramount BioCapital Asset Management Investments
26 Investments
Paramount BioCapital Asset Management has made 26 investments. Their latest investment was in Tracon Pharmaceuticals as part of their Series A on April 4, 2011.
Paramount BioCapital Asset Management Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
4/6/2011 | Series A | Tracon Pharmaceuticals | $14M | Yes | Arcus Ventures, Brookline Investments, JAFCO, Nextech Venture, and Undisclosed Venture Investors | 2 |
2/11/2011 | PIPE | Cascadian Therapeutics | $0.15M | Yes | Atoll Asset Management, AXA, Bristol Capital Advisors, Cantara, Cowen, Dafna Capital Management, Deerfield Management, Downsview Capital, Evolution Capital Management, Global Capital Partners, Heights Capital Management, Highbridge Capital Management, Hudson Bay Capital Management, Iroquois Capital Group, JGB Management, RG Capital, Rockmore Capital, Tail Wind Fund, and Undisclosed Venture Investors | |
7/19/2007 | PIPE - IV | Antares Pharma | $16M | No | ||
6/14/2007 | Unattributed VC - III | |||||
5/23/2007 | Unattributed VC - III |
Date | 4/6/2011 | 2/11/2011 | 7/19/2007 | 6/14/2007 | 5/23/2007 |
|---|---|---|---|---|---|
Round | Series A | PIPE | PIPE - IV | Unattributed VC - III | Unattributed VC - III |
Company | Tracon Pharmaceuticals | Cascadian Therapeutics | Antares Pharma | ||
Amount | $14M | $0.15M | $16M | ||
New? | Yes | Yes | No | ||
Co-Investors | Arcus Ventures, Brookline Investments, JAFCO, Nextech Venture, and Undisclosed Venture Investors | Atoll Asset Management, AXA, Bristol Capital Advisors, Cantara, Cowen, Dafna Capital Management, Deerfield Management, Downsview Capital, Evolution Capital Management, Global Capital Partners, Heights Capital Management, Highbridge Capital Management, Hudson Bay Capital Management, Iroquois Capital Group, JGB Management, RG Capital, Rockmore Capital, Tail Wind Fund, and Undisclosed Venture Investors | |||
Sources | 2 |
Paramount BioCapital Asset Management Portfolio Exits
12 Portfolio Exits
Paramount BioCapital Asset Management has 12 portfolio exits. Their latest portfolio exit was Antares Pharma on April 13, 2022.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
4/13/2022 | Acq - Pending | 4 | |||
3/9/2018 | Acq - P2P | 4 | |||
6/24/2017 | Acq - P2P | 2 | |||
Date | 4/13/2022 | 3/9/2018 | 6/24/2017 | ||
|---|---|---|---|---|---|
Exit | Acq - Pending | Acq - P2P | Acq - P2P | ||
Companies | |||||
Valuation | |||||
Acquirer | |||||
Sources | 4 | 4 | 2 |
Paramount BioCapital Asset Management Acquisitions
1 Acquisition
Paramount BioCapital Asset Management acquired 1 company. Their latest acquisition was Enhance Biotech on May 24, 2006.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
5/24/2006 | Acquired |
Date | 5/24/2006 |
|---|---|
Investment Stage | |
Companies | |
Valuation | |
Total Funding | |
Note | Acquired |
Sources |
Paramount BioCapital Asset Management Team
3 Team Members
Paramount BioCapital Asset Management has 3 team members, including current Managing Director, Asher Nathan.
Name | Work History | Title | Status |
|---|---|---|---|
Asher Nathan | Managing Director | Current | |
Scott A. Katzmann | OpusPoint Partners, Opus, First Boston, and Credit Suisse | Senior Managing Director | Former |
Nickolay Kukekov | Summer Street Research Partners, Rodman & Renshaw, and Columbia University | Managing Director | Former |
Name | Asher Nathan | Scott A. Katzmann | Nickolay Kukekov |
|---|---|---|---|
Work History | OpusPoint Partners, Opus, First Boston, and Credit Suisse | Summer Street Research Partners, Rodman & Renshaw, and Columbia University | |
Title | Managing Director | Senior Managing Director | Managing Director |
Status | Current | Former | Former |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.